Asset Details
Do you wish to reserve the book?
Lifting the fog in intermediate-risk (submassive) PE: full dose, low dose, or no thrombolysis? version 1; peer review: 2 approved
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Lifting the fog in intermediate-risk (submassive) PE: full dose, low dose, or no thrombolysis? version 1; peer review: 2 approved
Do you wish to request the book?
Lifting the fog in intermediate-risk (submassive) PE: full dose, low dose, or no thrombolysis? version 1; peer review: 2 approved
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Lifting the fog in intermediate-risk (submassive) PE: full dose, low dose, or no thrombolysis? version 1; peer review: 2 approved
2019
Overview
Acute pulmonary embolism (PE) is a disease frequently encountered in clinical practice. While the management of haemodynamically stable, low risk patients with acute PE is well established, managing intermediate disease often presents a therapeutic dilemma. In this review, we discuss the various therapeutic options available in this patient group. This includes thrombolysis, surgical embolectomy and catheter directed techniques. We have also explored the role of specialist PE response teams in the management of such patients.
